Trial Profile
A randomized study of sugammadex verses neostigmine-atropine combination in patients with cardiac problems undergoing noncardiac surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2016
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Atropine; Neostigmine
- Indications Cardiovascular disorders
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2016 New trial record